Invenomic Capital Management LP: NGD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Invenomic Capital Management LP on NGD, newest first. How the timeline and the estimate are built.
Invenomic Capital Management LP held 0 NGD shares at 2025-09-30 per its 13F-HR filed 2025-11-14.
the latest 13F is the newest step
- period ended2025-09-3013F 0 sharesChange vs previous 13F -4,227,089 shares
13F-HR 0001214659-25-016624 filed by Invenomic Capital Management LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-06-3013F 4,227,089 sharesChange vs previous 13F +815,337 shares
1.19% of the 13F portfolio, value $20,924,091.
13F-HR 0001214659-25-012218 filed by Invenomic Capital Management LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,411,752 sharesChange vs previous 13F +52,360 shares
0.64% of the 13F portfolio, value $12,657,600.
13F-HR 0001214659-25-007823 filed by Invenomic Capital Management LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,359,392 sharesChange vs previous 13F -660,988 shares
0.47% of the 13F portfolio, value $8,331,292.
13F-HR 0001214659-25-002834 filed by Invenomic Capital Management LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 4,020,380 sharesChange vs previous 13F not available
0.64% of the 13F portfolio, value $11,578,694.
13F-HR 0001214659-24-019131 filed by Invenomic Capital Management LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).